About Contact Us Careers

Plasma Expressor Machine Market Trends

Request Free Sample Copy

Report ID: 3991
Published Date: Aug 20, 2024
Report Format: PDF, PPT

Buy Now

Plasma Expressor Machine Market Trends

Growth Drivers

Increasing Prevalence of Blood Cancer
Growing Demand for Transfusion of Different Components of Blood
Advancement in Medical Technologies

Challenges

Limited Availability of Advanced Technology
High Initial Price and Maintenance Cost

Plasma Expressor Machine Market: Key Insights

Base Year	2023
Forecast Year	2024–2036
CAGR	3.5%
Base Year Market Size (2023)	USD 109.2 million
Forecast Year Market Size (2036)	USD 170.78 million
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Plasma Expressor Machine Market Size & Share, Growth Analysis 2036

Author Credits: Radhika Pawar

Report ID: 3991
Published Date: Aug 20, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of plasma expressor machine is evaluated at USD 112.26 million.

Plasma Expressor Machine Market size was over USD 109.2 million in 2023 and is projected to reach USD 170.78 million by 2036, growing at around 3.5% CAGR during the forecast period i.e., between 2024-2036. Increasing prevalence of blood cancer, and other disorders will boost the market growth.

North America industry is estimated to hold largest revenue share by 2036, led by high prevalence of leukemia and lymphoma in the region.

The major players in the market are Escape Therapeutics, Inc., Regen BioPharma, Inc., ThermoGenesis Holdings, Inc., CSG-BIO Company, Inc. (CellSave), CBR Systems, Inc., Pluristem Inc., ViaCord, LLC, and Cynata Therapeutics Limited.

Inquiry Before Buying Request Free Sample